A GABAB receptor agonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

SKF 97541

Item No. 43784

Technical Information
Formal Name
P-(3-aminopropyl)-P-methyl-phosphinic acid
CAS Number
127729-35-5
Synonyms
  • CGP 35024
Molecular Formula
C4H12NO2P
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
Water: Slightly soluble: 0.1-1 mg/ml
SMILES
O=P(C)(CCCN)O
InChi Code
InChI=1S/C4H12NO2P/c1-8(6,7)4-2-3-5/h2-5H2,1H3,(H,6,7)
InChi Key
NHVRIDDXGZPJTJ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    SKF 97541 is a GABAB receptor agonist.1 It reduces forskolin-induced cAMP accumulation in rat cortical slices when used at concentrations of 30 and 100 µM.2 SKF 97541 reduces excitatory postsynaptic potentials (EPSPs) induced by bicuculline (Item No. 11727) in rat striatal slices (EC50 = 0.092 µM), an effect that can be blocked by CGP 35348 (Item No. 18599).3 It also hyperpolarizes neurons in the substantia nigra in rat brain slices (EC50 = 0.15 µM). SKF 19541 (0.01 and 0.05 mg/kg) reduces the time spent immobile in the forced swim test in rats without reducing basal locomotor activity.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Froestl, W., Mickel, S.J., von Sprecher, G., et alPhosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists. J. Med. Chem. 38(17), 3313-3331 (1995).

    2. Wierońska, J.M., Kłeczek, N., Woźniak, M., et almGlu5-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia. Neurochem. Int. 88, 97-109 (2015).

    3. Seabrook, G.R., Howson, W., and Lacey, M.G. Electrophysiological characterization of potent agonists and antagonists at pre- and postsynaptic GABAB receptors on neurones in rat brain slices. Br. J. Pharmacol. 101(4), 949-957 (1990).

    4. Frankowska, M., Filip, M., and Przegaliński, E. Effects of GABAB receptor ligands in animal tests of depression and anxiety. Pharmacol. Rep. 59(6), 645-655 (2007).